Literature DB >> 8838158

Effects of methylphenidate (Ritalin) on mammalian myocardial ultrastructure.

T A Henderson1, V W Fischer.   

Abstract

Previous observations have indicated lamellated ultrastructural lesions in the myocardium of a patient treated with methylphenidate (Ritalin) hydrochloride (MPH). A causal relationship between MPH exposure and these membranous changes was tested in the myocardium of rats and mice. Following injection of varying doses of MPH for different periods, myocardial ultrastructure was examined and lesions were quantified by stereological techniques. Myocardial tissue also was stained using techniques selective for acid phosphatase and for sarcoplasmic reticulum to identify possible pathogenetic mechanisms. MPH induced membrane accumulations and lamellations which were not membrane-bound and did not react for acid phosphatase, but stained positively for sarcoplasmic reticulum. Both lesions were highly focal, surrounded by normal appearing myocardial tissue. Lamellations were evident at the earliest timepoints examined and appeared to occur without lysosomal involvement. Lesions were still apparent 12 weeks after terminating MPH. These data suggest that MPH may have persistent, cumulative effects on the myocardium.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8838158

Source DB:  PubMed          Journal:  Am J Cardiovasc Pathol        ISSN: 0887-8005


  8 in total

1.  Cardiovascular safety of stimulants in children with attention-deficit/hyperactivity disorder: a nationwide prospective cohort study.

Authors:  Søren Dalsgaard; Anette Primdal Kvist; James F Leckman; Helena Skyt Nielsen; Marianne Simonsen
Journal:  J Child Adolesc Psychopharmacol       Date:  2014-06-23       Impact factor: 2.576

Review 2.  Assessment of potential cardiovascular risks of methylphenidate in comparison with sibutramine: do we need a SCOUT (trial)?

Authors:  Jochen Antel; Özgür Albayrak; Gerd Heusch; Tobias Banaschewski; Johannes Hebebrand
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-08-23       Impact factor: 5.270

3.  Combining parent and child training for young children with ADHD.

Authors:  Carolyn H Webster-Stratton; M Jamila Reid; Ted Beauchaine
Journal:  J Clin Child Adolesc Psychol       Date:  2011

Review 4.  Adverse effects of pharmacotherapies for attention-deficit hyperactivity disorder: epidemiology, prevention and management.

Authors:  Johnny Graham; David Coghill
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

5.  Methylphenidate off-label use and safety.

Authors:  Thierry Trenque; Emmanuelle Herlem; Malak Abou Taam; Moustapha Drame
Journal:  Springerplus       Date:  2014-06-07

6.  A randomized controlled laboratory study on the long-term effects of methylphenidate on cardiovascular function and structure in rhesus monkeys.

Authors:  James D Wilkinson; Ralph Callicott; William F Salminen; Satinder K Sandhu; James Greenhaw; Angel Paredes; Kelly Davis; Yvonne Jones; Merle G Paule; William Slikker; Paolo G Rusconi; Jason Czachor; Amy Bodien; Joslyn A Westphal; Danielle D Dauphin; Steven E Lipshultz
Journal:  Pediatr Res       Date:  2018-12-17       Impact factor: 3.756

7.  A young man with acute dilated cardiomyopathy associated with methylphenidate.

Authors:  Tor-Bjarne Nymark; A Hovland; H Bjørnstad; E W Nielsen
Journal:  Vasc Health Risk Manag       Date:  2008

Review 8.  Practical application of the neuroregenerative properties of ketamine: real world treatment experience.

Authors:  Theodore A Henderson
Journal:  Neural Regen Res       Date:  2016-02       Impact factor: 5.135

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.